REVIVA PHARMACEUTICALS HOLDINGS, INC. Annual Depreciation in USD from 2019 to 2021

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Reviva Pharmaceuticals Holdings, Inc. quarterly/annual Depreciation history and growth rate from 2019 to 2021.
  • Reviva Pharmaceuticals Holdings, Inc. Depreciation for the quarter ending March 31, 2024 was $0.000.
  • Reviva Pharmaceuticals Holdings, Inc. annual Depreciation for 2021 was $0.000, a 100% decline from 2020.
  • Reviva Pharmaceuticals Holdings, Inc. annual Depreciation for 2020 was $591.000, a 8.37% decline from 2019.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $0 -$591 -100% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-15
2020 $591 -$54 -8.37% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 $645 Jan 1, 2019 Dec 31, 2019 10-K/A 2021-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.